BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 27356714)

  • 1. Association of Estrogen Receptor Alpha and Interleukin 6 Polymorphisms with Lymphovascular Invasion, Extranodal Extension, and Lower Disease-Free Survival in Thai Breast Cancer Patients.
    Sa-Nguanraksa D; Suntiparpluacha M; Kulprom A; Kummalue T; Chuangsuwanich T; Avirutnan P; O-Charoenrat P
    Asian Pac J Cancer Prev; 2016; 17(6):2935-40. PubMed ID: 27356714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of ESR1, UGT1A1, HCN1, MAP3K1 and CYP2B6 are associated with the prognosis of hormone receptor-positive early breast cancer.
    Kuo SH; Yang SY; You SL; Lien HC; Lin CH; Lin PH; Huang CS
    Oncotarget; 2017 Mar; 8(13):20925-20938. PubMed ID: 28178648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen receptor alpha polymorphisms: correlation with clinicopathological parameters in breast cancer.
    Anghel A; Raica M; Narita D; Seclaman E; Nicola T; Ursoniu S; Anghel M; Popovici E
    Neoplasma; 2010; 57(4):306-15. PubMed ID: 20429621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HER2 Codon 655 (Ile/Val) Polymorphism and Breast Cancer in Austrian Women.
    Watrowski R; Castillo-Tong DC; Wolf A; Schuster E; Fischer MB; Speiser P; Zeillinger R
    Anticancer Res; 2015 Nov; 35(11):5901-4. PubMed ID: 26504013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant association between ERCC2 and MTHR polymorphisms and breast cancer susceptibility in Moroccan population: genotype and haplotype analysis in a case-control study.
    Hardi H; Melki R; Boughaleb Z; El Harroudi T; Aissaoui S; Boukhatem N
    BMC Cancer; 2018 Mar; 18(1):292. PubMed ID: 29544444
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP17 (T-34C) and CYP19 (Trp39Arg) polymorphisms and their cooperative effects on breast cancer susceptibility.
    Tüzüner BM; Oztürk T; Kisakesen HI; Ilvan S; Zerrin C; Oztürk O; Isbir T
    In Vivo; 2010; 24(1):71-4. PubMed ID: 20133979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between RAD51D germline mutations and breast cancer risk and survival in BRCA1/2-negative breast cancers.
    Chen X; Li Y; Ouyang T; Li J; Wang T; Fan Z; Fan T; Lin B; Xie Y
    Ann Oncol; 2018 Oct; 29(10):2046-2051. PubMed ID: 30165555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of CASP8 rs10931936 and rs1045485 Polymorphisms as well as the Haplotypes on Breast Cancer Risk: A Case-Control Study.
    Vahednia E; Shandiz FH; Bagherabad MB; Moezzi A; Afzaljavan F; Tajbakhsh A; Kooshyar MM; Pasdar A
    Clin Breast Cancer; 2019 Oct; 19(5):e563-e577. PubMed ID: 31362911
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Novel Breast Cancer Risk Loci.
    Chan CHT; Munusamy P; Loke SY; Koh GL; Wong ESY; Law HY; Yoon CS; Tan MH; Yap YS; Ang P; Lee ASG
    Cancer Res; 2017 Oct; 77(19):5428-5437. PubMed ID: 28775167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prevalence of estrogen receptor-1 mutation in advanced breast cancer: The estrogen receptor one study (EROS1).
    Najim O; Huizing M; Papadimitriou K; Trinh XB; Pauwels P; Goethals S; Zwaenepoel K; Peterson K; Weyler J; Altintas S; van Dam P; Tjalma W
    Cancer Treat Res Commun; 2019; 19():100123. PubMed ID: 30826563
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common germline polymorphisms in COMT, CYP19A1, ESR1, PGR, SULT1E1 and STS and survival after a diagnosis of breast cancer.
    Udler MS; Azzato EM; Healey CS; Ahmed S; Pooley KA; Greenberg D; Shah M; Teschendorff AE; Caldas C; Dunning AM; Ostrander EA; Caporaso NE; Easton D; Pharoah PD
    Int J Cancer; 2009 Dec; 125(11):2687-96. PubMed ID: 19551860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No association of hypoxia inducible factor-1α gene polymorphisms with breast cancer in North-West Indians.
    Sharma S; Kapahi R; Sambyal V; Guleria K; Manjari M; Sudan M; Uppal MS; Singh NR
    Asian Pac J Cancer Prev; 2014; 15(22):9973-8. PubMed ID: 25520138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL6 genotype, tumour ER-status, and treatment predicted disease-free survival in a prospective breast cancer cohort.
    Markkula A; Simonsson M; Ingvar C; Rose C; Jernström H
    BMC Cancer; 2014 Oct; 14():759. PubMed ID: 25305747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the IL-10 gene rs1800872 (-592 C>A) polymorphism with breast cancer in a Mexican population.
    Patricia Gallegos-Arreola M; Zúñiga González GM; Figuera LE; Puebla Pérez AM; Delgado Saucedo JI
    J BUON; 2019; 24(6):2369-2376. PubMed ID: 31983108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of genetic polymorphisms of ER-alpha and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women.
    Zhang L; Gu L; Qian B; Hao X; Zhang W; Wei Q; Chen K
    Breast Cancer Res Treat; 2009 Mar; 114(2):327-38. PubMed ID: 18629629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the -2518 A/G Polymorphism of MCP-1 with Breast Cancer in Punjab, North-West India.
    Sambyal V; Guleria K; Kapahi R; Manjari M; Sudan M; Uppal MS; Singh NR
    Asian Pac J Cancer Prev; 2015; 16(16):7243-8. PubMed ID: 26514518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genotypic and haplotype analysis of Interleukin-6 and -18 gene polymorphisms in association with clinicopathological factors in breast cancer.
    Padala C; Puranam K; Shyamala N; Kupsal K; Kummari R; Galimudi RK; Gundapaneni KK; Tupurani MA; Suryadevera A; Chinta SK; Manavathi B; Hanumanth SR
    Cytokine; 2022 Dec; 160():156024. PubMed ID: 36182709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ADRA2A Germline Gene Polymorphism is Associated to the Severity, but not to the Risk, of Breast Cancer.
    Kaabi B; Belaaloui G; Benbrahim W; Hamizi K; Sadelaoud M; Toumi W; Bounecer H
    Pathol Oncol Res; 2016 Apr; 22(2):357-65. PubMed ID: 26563278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MMP-2 -735 C allele is a risk factor for susceptibility to breast cancer.
    Yari K; Rahimi Z; Moradi MT; Rahimi Z
    Asian Pac J Cancer Prev; 2014; 15(15):6199-203. PubMed ID: 25124598
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The C609T (Pro187Ser) Null Polymorphism of the NQO1 Gene Contributes Significantly to Breast Cancer Susceptibility in North Indian Populations: a Case Control Study.
    Yadav P; Mir R; Nandi K; Javid J; Masroor M; Ahmad I; Zuberi M; Kaza R; Jain S; Khurana N; Ray PC; Saxena A
    Asian Pac J Cancer Prev; 2016; 17(3):1215-9. PubMed ID: 27039751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.